University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Soonmee Cha, MD

Soonmee Cha, MD

Assistant Professor, Department of Radiology, UCSF

Cancer Center Program Memberships

Neurologic Oncology

Research Summary

Soonmee Cha, MD, is a Professor In Residence of Radiology and Neurological Surgery at the University of California, San Francisco. She is the Diagnostic Radiology Residency Program Director, and she is Radiology's Vice-Chair of Education. Dr. Cha has focused on the importance of validating the usefulness of MRI as a tool for brain tumor diagnosis, monitoring and identifying therapy endpoints. She obtained her medical degree from Georgetown University, School of Medicine, Washington in 1991. She completed her Diagnostic Radiology residency from North Shore University Hospital, Cornell University Medical College in New York, followed by a fellowship in Neuroradiology from New York University Medical Center in 1998.

Dr. Cha is committed to a career dedicated to patient-oriented research in the field of brain tumor imaging. She believes that non-invasive imaging technology will make important contributions to the health of patients through improving the specificity and precision of diagnosis and treatment monitoring, which will have significant impact on therapeutic decisions.

The main focus of Dr. Cha’s research is to identify reliable surrogate markers of prognosis and therapeutic efficacy by quantitative MR imaging methods in patients with brain tumors. She believes that by using MR imaging techniques such perfusion MR imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging, detection of changes in tumor angiogenesis, cellularity, invasion, tumor hypoxia, and metabolic burden can be accurately measured and will provide more specific information about patient’s early response to therapy in the context of tumor growth.

Dr. Cha has been awarded several NIH grants, serving as Principal Investigator and Co-Principal Investigator on many NIH projects. She has published 87 articles, and she has written 77 peer-reviewed articles and 4 book chapters.

Expertise:

Neuroradiology

Specialty:

Brain tumor imaging

Professional Interests:

Brain tumor, brain cancer, glioblastoma multiforme, gliomas, primary cerebral lymphoma, angiogenesis, hypoxia, invasion, perfusion MR imaging, diffusion-weighted imaging, molecular imaging, biomarkers, microarray, genomics, neural stem cell

Education and Training:

• Medical School: Georgetown University, College of Arts and Sciences, Washington, District of Columbia

• Internship: Georgetown University Fairfax Hospital, Falls Church

• Residency: North Shore University Hospital, Cornell University Medical College, Manhasset, New York - Diagnostic Radiology

• Fellowship: New York University Medical Center, New York - Neuroradiology

Education

Georgetown University, Washington, DC, B.S., 1983-1987, Chemistry
Georgetown University, Washington, DC, M.D., 1987-1991, Medicine
Georgetown University Hospital, Washington, DC, Internship, 1991-1992, Transitional Internship
North Shore University Hospital, Manhasset, NY, Residency, 1992-1996, Diagnostic Radiology
New York University Medical Center, New York, NY, Fellowship, 1996-1998, Neuroradiology


Professional Experience

  • 1997-1998
    Clinical Instructor of Neuroradiology, New York University Medical Center, New York, NY
  • 1998-2000
    Assistant Professor of Radiology, New York University School of Medicine
  • 2001-present
    Assistant Professor of Radiology, University of California, San Francisco School of Medicine

Honors & Awards

  • April 2000
    ASNR Outstanding Presentation Award in General Neuroradiology at the 38th Annual Meeting in Atlanta, GA.
  • 1995
    Certificate of Merit Award, Scientific exhibit at RSNA
  • 1994
    Certificate of Merit Award, Scientific exhibit at RSNA

Selected Publications

  1. Merritt BA, Henry TS, Cha S, Ordovas KG, Kallianos KG, Elicker BM, Hope MD, Naeger DM. Tailoring Radiology Resident Education Using Aggregated Missed-Cases Data. J Am Coll Radiol. 2018 May 11.
    View on PubMed
  2. Weinberg BD, Boreta L, Braunstein S, Cha S. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma. J Neurooncol. 2018 Mar 15.
    View on PubMed
  3. Villanueva-Meyer JE, Wood MD, Choi BS, Mabray MC, Butowski NA, Tihan T, Cha S. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis. AJR Am J Roentgenol. 2018 Mar; 210(3):621-628.
    View on PubMed
  4. Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol. 2017 Dec; 10(6):895-903.
    View on PubMed
  5. Barajas RF, Villanueva-Meyer J, Perry A, Berger M, Cha S. Biologically aggressive regions within glioblastoma identified by spin-lock contrast T1 relaxation in the rotating frame (T1?) MRI. Radiol Case Rep. 2017 Dec; 12(4):827-832.
    View on PubMed
  6. Villanueva-Meyer JE, Mabray MC, Cha S. Current Clinical Brain Tumor Imaging. Neurosurgery. 2017 Sep 01; 81(3):397-415.
    View on PubMed
  7. Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S. Case-based review: pediatric medulloblastoma. Neurooncol Pract. 2017 Sep; 4(3):138-150.
    View on PubMed
  8. Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. J Neurol Sci. 2017 Oct 15; 381:83-87.
    View on PubMed
  9. Villanueva-Meyer JE, Han SJ, Cha S, Butowski NA. Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes. J Neurooncol. 2017 Aug; 134(1):213-219.
    View on PubMed
  10. Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, Butowski N, Raffel C, Tihan T, Bollen AW, Phillips JJ, Korn WM, Yeh I, Bastian BC, Gupta N, Mueller S, Perry A, Nicolaides T, Solomon DA. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 2017 05 01; 19(5):699-709.
    View on PubMed
  11. Li Y, Ali S, Clarke J, Cha S. Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications. Brain Tumor Res Treat. 2017 Apr; 5(1):1-9.
    View on PubMed
  12. Cha SM, Shin HD, Ahn KJ. Prognostic Factors Affecting Union After Ulnar Shortening Osteotomy in Ulnar Impaction Syndrome: A Retrospective Case-Control Study. J Bone Joint Surg Am. 2017 Apr 19; 99(8):638-647.
    View on PubMed
  13. Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017 Nov; 46(5):1247-1262.
    View on PubMed
  14. Nelson SJ, Kadambi AK, Park I, Li Y, Crane J, Olson M, Molinaro A, Roy R, Butowski N, Cha S, Chang S. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen. Neuro Oncol. 2017 03 01; 19(3):430-439.
    View on PubMed
  15. Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. J Neurooncol. 2017 03; 132(1):171-179.
    View on PubMed
  16. Barajas RF, Krohn KA, Link JM, Hawkins RA, Clarke JL, Pampaloni MH, Cha S. Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines. 2016 Oct 31; 4(4).
    View on PubMed
  17. Mabray MC, Cha S. Advanced MR Imaging Techniques in Daily Practice. Neuroimaging Clin N Am. 2016 Nov; 26(4):647-666.
    View on PubMed
  18. Barajas RF, Cha S. Metastasis in Adult Brain Tumors. Neuroimaging Clin N Am. 2016 Nov; 26(4):601-620.
    View on PubMed
  19. Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. J Neurooncol. 2016 10; 130(1):171-179.
    View on PubMed
  20. Barajas RF, Butowski NA, Phillips JJ, Aghi MK, Berger MS, Chang SM, Cha S. The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma. Acad Radiol. 2016 Sep; 23(9):1073-82.
    View on PubMed

Go to UCSF Profiles, powered by CTSI